Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
WuXi XDC Cayman
Watchlist
Pre-IPO WuXi XDC (PHIP Updates) - Some Points Worth the Attention
Equity Capital Markets
454 Views
01 Nov 2023 00:55
WuXi XDC’s share price could perform well due to positive sentiments on ADC.But if the real market size of ADC is much smaller than PD-1,imagination space of WuXi XDC's outlook will be greatly reduced
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »
Loading
Trending Collections
More »
India
Equity Derivatives
Event-Driven
South Korea
Equity Bottom-Up
Technical Analysis
Philippines
Commodities
Index Rebalance
Asia Event-Driven
Trending Insights
More »
Toyota Industries (6201) - Thinking About How To Value a ¥6trln Bid
HEW: Good News From Less News
Hainan Meilan Intl Airport (357 HK): Hainan SASAC's Left/Right Pocket MGO
StubWorld: On Valuing Toyota Industries (6201)'s Stub Ops
Meilan Airport (357 HK): Possible Unconditional MGO at HK$10.62
Top Unpaywalled Insights
More »
[IO Technicals Weekly 2025/18]: Bearish Momentum Strengthens
Gensol Engineering Scandal: Our AI System Saw This Coming
Europe Vs NATO & Trump - U/W Bonds
Overview#24 – Exiting No Man’s Land
[IO Technicals Weekly 2025/17] Bullish Momentum Builds
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
CanSino Biologics (6185.HK/688185.CH) 23Q3 - Some Positive Business Progress Worth the Attention
07 Nov 2023
Interpretation of China’s Central Financial Work Conference – the Big Changes and the Outlook
06 Nov 2023
China Healthcare Weekly (Nov.3)-Share Price Correction,Valuable Shortcut,Globalization Vs Innovation
05 Nov 2023
Pre-IPO WuXi XDC (PHIP Updates) - Some Points Worth the Attention
01 Nov 2023
GLP-1 Drugs – Are They Dessert or Time Bomb to Your Portfolio?
16 Oct 2023
China's Weight Loss Drug Market – The Investment Opportunities and the Risks Behind
09 Oct 2023
Pre-IPO WuXi XDC - The Beautiful Story and the Truth Behind
17 Jul 2023
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.2
x